SIV

Christopher A Gonelli1, Hannah A D King1,2,3, SungYoul Ko1

  • 1Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Nature
|February 5, 2025
PubMed
概括

广泛中和抗体 (bNAbs) 可以延迟但不能完全预防猿类免疫缺陷病毒 (SIV) 感染. 即使bNAb水平高,也发生了亚临床感染,影响了人类免疫缺陷病毒 (HIV-1) 预防试验的解释.